Ochate, Erwin R.
HRN: 09-45-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
ACICLOVIR 400MG (TAB)
04/14/2023
04/19/2023
PO
400
Q12h
Herpes Simplez
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes